Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04286711
What this trial is testing

Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
China Medical University, China 52
Testing effectiveness (Phase 2)Looking for participantsNCT06415669
What this trial is testing

Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital of Xiamen University 30
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Large-scale testing (Phase 3)Looking for participantsNCT07589244
What this trial is testing

VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC

Who this might be right for
HCC
Guangzhou Virotech Pharmaceutical Co., Ltd. 66
Testing effectiveness (Phase 2)Looking for participantsNCT05192798
What this trial is testing

Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC

Who this might be right for
Triple-negative Breast Cancer
The First Affiliated Hospital of Bengbu Medical University 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06786312
What this trial is testing

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Fujian Cancer Hospital 34
Testing effectiveness (Phase 2)UnknownNCT05142865
What this trial is testing

Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas

Who this might be right for
Advanced or Metastatic EP-NEC
Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614621
What this trial is testing

Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Fujian Cancer Hospital 43
Testing effectiveness (Phase 2)UnknownNCT03457467
What this trial is testing

Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

Who this might be right for
Breast Cancer
Yan Li 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07610629
What this trial is testing

Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric Adenocarcinoma
Henan Cancer Hospital 50
Testing effectiveness (Phase 2)UnknownNCT04454905
What this trial is testing

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07464756
What this trial is testing

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06363825
What this trial is testing

TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Fujian Medical University 57
Testing effectiveness (Phase 2)UnknownNCT04190745
What this trial is testing

Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study

Who this might be right for
Gastric Adenocarcinoma
Zhejiang Cancer Hospital 116
Testing effectiveness (Phase 2)Study completedNCT03660761
What this trial is testing

Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors

Who this might be right for
Efficacy and Safety
Rongjie Tao 25
Early research (Phase 1)UnknownNCT04073784
What this trial is testing

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 41
Testing effectiveness (Phase 2)UnknownNCT03950141
What this trial is testing

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

Who this might be right for
HER-2 Negatived Gastric Cancer
Beijing Hospital 30
Early research (Phase 1)UnknownNCT03244774
What this trial is testing

Phase I Study of the Combination of Apatinib and POF

Who this might be right for
Gastric Adenocarcinoma
Fujian Cancer Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT03777124
What this trial is testing

Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer

Who this might be right for
NSCLC Stage IVKRAS Gene MutationPD-1 Antibody+1 more
Jiangsu HengRui Medicine Co., Ltd. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07031154
What this trial is testing

A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerAdebrelimabApatinib
The First Affiliated Hospital of Xiamen University 43
Next Page